风险分层模型用于预测最初转移性小细胞肺癌的中国患者的整体生存率
Rong Fu1, Chuanqing Jing1, Wei Zhang2
1The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
Medicine
|October 21, 2024
概括
一种新型的诺米图准确地预测了中国转移性小细胞肺癌 (SCLC) 患者的整体存活率. 与传统系统相比,这种工具提供了更好的预后能力,有助于个性化治疗决策.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 癌症研究 癌症研究
背景情况:
- 转移性小细胞肺癌 (SCLC) 在治疗和预后方面存在重大挑战.
- 准确的预后工具对于指导SCLC治疗策略至关重要.
研究的目的:
- 开发和验证一种名谱和风险分层模型,用于预测最初转移性SCLC的中国患者的整体存活率.
- 为了比较开发的诺姆图的预后性能与美国癌症瘤节点转移联合委员会 (TNM) 已建立的分类系统.
主要方法:
- 利用监测,流行病学和最终结果 (SEER) 数据库 (2010-2015) 的数据用于培训和验证队列.
- 包括一个来自中国医院的外部验证队列 (198名患者).
- 采用单变量和多变量Cox比例危险回归模型来确定显著的预后因素.
主要成果:
- 确定了年龄,性别,学年级,化疗,肝转移和肺部侵袭作为独立的预后因素.
- 与TNM系统 (0.543) 相比,开发的名图显示出更高的预测准确性 (C指标0.75).
- 命名图和风险分层模型在内部和外部验证队列中显示出强大的准确性和一致性.
结论:
- 开发的诺米图为中国转移性SCLC患者提供了更准确和个性化的预后预测.
- 这种工具可以帮助临床医生做出明智的治疗建议,并改善患者管理.
- 在传统的TNM分期系统上,名图提供了显著的预后优势.
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:20Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155